Literature DB >> 34046621

Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice.

Baris A Borsa1, Mert Sudagidan2, Mehmet E Aldag3, Isik I Baris4, Elif E Acar2, Cagatay Acuner5, Murat Kavruk6, Veli C Ozalp7.   

Abstract

Antibiotic therapy comes with disturbances on human microbiota, resulting in changes of bacterial communities and thus leading to well-established health problems. In this study, we demonstrated that targeted teicoplanin administration maintains the faecal microbiota composition undisturbed in a mouse model while reaching therapeutic improvements for S. aureus infection. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID： 34046621      PMCID： PMC8130601          DOI： 10.1039/d0md00347f

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN： 2632-8682


  15 in total

1.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

2.  The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.

Authors:  Tetsuo Yamaguchi; Hiroe Konishi; Kotaro Aoki; Yoshikazu Ishii; Koji Chono; Kazuhiro Tateda
Journal:  J Infect Chemother       Date:  2020-03-09       Impact factor: 2.211

Review 3.  Shifting the balance: antibiotic effects on host-microbiota mutualism.

Authors:  Benjamin P Willing; Shannon L Russell; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2011-02-28       Impact factor: 60.633

4.  Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens.

Authors:  M Kavruk; O Celikbicak; V C Ozalp; B A Borsa; F J Hernandez; G Bayramoglu; B Salih; M Y Arica
Journal:  Chem Commun (Camb)       Date:  2015-05-18       Impact factor: 6.222

Review 5.  The challenge of antimicrobial resistance: What economics can contribute.

Authors:  Laurence S J Roope; Richard D Smith; Koen B Pouwels; James Buchanan; Lucy Abel; Peter Eibich; Christopher C Butler; Pui San Tan; A Sarah Walker; Julie V Robotham; Sarah Wordsworth
Journal:  Science       Date:  2019-04-05       Impact factor: 47.728

Review 6.  Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review.

Authors:  Ramesh Thevendran; Shigdar Sarah; Thean-Hock Tang; Marimuthu Citartan
Journal:  J Control Release       Date:  2020-05-05       Impact factor: 9.776

Review 7.  Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.

Authors:  Simone Becattini; Ying Taur; Eric G Pamer
Journal:  Trends Mol Med       Date:  2016-05-10       Impact factor: 11.951

8.  Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice.

Authors:  A S Lee; D L Gibson; Y Zhang; H P Sham; B A Vallance; J P Dutz
Journal:  Diabetologia       Date:  2009-12-13       Impact factor: 10.122

9.  Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.

Authors:  Samet Ucak; Mert Sudagidan; Baris A Borsa; Banu Mansuroglu; Veli C Ozalp
Journal:  World J Microbiol Biotechnol       Date:  2020-04-25       Impact factor: 3.312

Review 10.  Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.

Authors:  Maria C Opazo; Elizabeth M Ortega-Rocha; Irenice Coronado-Arrázola; Laura C Bonifaz; Helene Boudin; Michel Neunlist; Susan M Bueno; Alexis M Kalergis; Claudia A Riedel
Journal:  Front Microbiol       Date:  2018-03-12       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.